Jubilant Generics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?
JUBILANT GENERICS has thirty-seven approved drugs.
Summary for Jubilant Generics
| US Patents: | 0 |
| Tradenames: | 33 |
| Ingredients: | 32 |
| NDAs: | 37 |
| Patent Litigation for Jubilant Generics: | See patent lawsuits for Jubilant Generics |
Drugs and US Patents for Jubilant Generics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Generics | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 209156-003 | May 14, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Jubilant Generics | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 203252-002 | Dec 31, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Jubilant Generics | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 203613-002 | Jun 19, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
